Form SC 13D/A STREAMLINE HEALTH SOLUTI Filed by: Tamarack Advisers, LP

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D
(Amendment No. 1)

Under the Securities Exchange Act of 1934


Streamline Health Solutions Inc.
(Name of Issuer)

Common Stock, $0.01 par value
(Title of Class of Securities)

86323X106
(CUSIP Number)

Melissa Dehn
305 SE Chkalov Dr., Suite 111-322
Vancouver, WA  98683
(360) 737-4153
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

03/02/2021
(Date of Event which Requires
Filing of this Statement)

If the filing person has previously filed a statement on 
Schedule 13G to report the acquisition which is the subject of 
this Schedule 13D, and is filing this schedule because of 
240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following 
box. [X].

Note:  Schedules filed in paper format shall include a signed 
original and five copies of the schedule, including all 
exhibits. See 240.13d-7 for other parties to whom copies are to 
be sent.

*The remainder of this cover page shall be filled out for a 
reporting person's initial filing on this form with respect to 
the subject class of securities, and for any subsequent 
amendment containing information which would alter the 
disclosures provided in a prior cover page.

The information required in the remainder of this cover page 
shall not be deemed to be "filed" for the purpose of Section 18 
of the Securities Exchange Act of 1934 ("Act") or otherwise 
subject to the liabilities of that section of the Act but shall 
be subject to all other provisions of the Act (however, see the 
Notes).


CUSIP No. 86323X106	SCHEDULE 13D	Page 2 of 10



 1   Name of Reporting Person	
     Justin J. Ferayorni
     IRS Identification No. of Above Person	
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]


 3   SEC USE ONLY



 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings 
     is Required Pursuant to Items 2(d) or 2(e)             [ ]


 6   Citizenship or Place of Organization
     United States Citizen

     NUMBER OF         7   Sole Voting Power           5,036,063
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      5,036,063
     PERSON 
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting 
Person
     5,036,063

12   Check Box if the Aggregate Amount in Row 11 Excludes 
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     12.1%

14   Type of Reporting Person
     IN



CUSIP No. 86323X106	SCHEDULE 13D	Page 3 of 10



 1   Name of Reporting Person	
     Tamarack Capital GP, LLC
     IRS Identification No. of Above Person	47-4492240
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]


 3   SEC USE ONLY



 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings 
     is Required Pursuant to Items 2(d) or 2(e)             [ ]


6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,930,882
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,930,882
     PERSON 
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting 
Person
     4,930,882

12   Check Box if the Aggregate Amount in Row 11 Excludes 
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     11.8%

14   Type of Reporting Person
     HC



CUSIP No. 86323X106	SCHEDULE 13D	Page 4 of 10



 1   Name of Reporting Person	
     Tamarack Advisers, LP
     IRS Identification No. of Above Person	47-4492240
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]


 3   SEC USE ONLY



 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings 
     is Required Pursuant to Items 2(d) or 2(e)             [ ]


6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,930,882
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,930,882
     PERSON 
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting 
Person
     4,930,882

12   Check Box if the Aggregate Amount in Row 11 Excludes 
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     11.8%

14   Type of Reporting Person
     IA



CUSIP No. 86323X106	SCHEDULE 13D	Page 5 of 10



 1   Name of Reporting Person	
     Tamarack Capital Management, LLC
     IRS Identification No. of Above Person	90-0292676
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]


 3   SEC USE ONLY



 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings 
     is Required Pursuant to Items 2(d) or 2(e)             [ ]


6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,930,882
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,930,882
     PERSON 
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting 
Person
     4,930,882

12   Check Box if the Aggregate Amount in Row 11 Excludes 
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     11.8%

14   Type of Reporting Person
     HC



CUSIP No. 86323X106	SCHEDULE 13D	Page 6 of 10



 1   Name of Reporting Person	
     Tamarack Global Healthcare Fund, L.P.
     IRS Identification No. of Above Person	20-8297742
     (entities only)

 2   Check the Appropriate Box if a Member of a Group*  (a) [ ]
                                                        (b) [ ]


 3   SEC USE ONLY



 4   Source of Funds                                         WC

 5   Check Box if Disclosure of Legal Proceedings 
     is Required Pursuant to Items 2(d) or 2(e)             [ ]


6   Citizenship or Place of Organization
     Delaware

     NUMBER OF         7   Sole Voting Power           4,223,334
     SHARES
     BENEFICIALLY      8   Shared Voting Power         -0-
     OWNED BY EACH
     REPORTING         9   Sole Dispositive Power      4,223,334
     PERSON 
     WITH             10   Shared Dispositive Power    -0-

11   Aggregate Amount Beneficially Owned by Each Reporting 
Person
     4,223,334

12   Check Box if the Aggregate Amount in Row 11 Excludes 
Certain Shares
     [ ]

13   Percent of Class Represented by Amount in Row 11
     10.1%

14   Type of Reporting Person
     PN



 
CUSIP No. 86323X106	SCHEDULE 13D	Page 7 of 10


Item 1.   Security and Issuer

This Schedule 13D ("Schedule") relates to shares of Common 
Stock, $0.01 par value (the "Common Stock"), of Streamline 
Health Solutions Inc. (the "Issuer").  The principal executive 
office of the Issuer is 11800 Amber Park Drive, Suite 125, 
Atlanta, GA  30009.  

Item 2.   Identity and Background

This Schedule is filed on behalf of the following entities:  

Justin John Ferayorni, a United States Citizen.  
Tamarack Capital GP, LLC, a Delaware limited liability company 
("Tamarack GP")
Tamarack Advisers, LP, a Delaware limited partnership("Tamarack 
IA")
Tamarack Capital Management, LLC, a Delaware limited liability 
company("Tamarack PFGP")
Tamarack Global Healthcare Fund, L.P., a Delaware limited 
partnership("Tamarack GHF")

The business address of the reporting entities is 5050 Avenida 
Encinas, Suite 360, Carlsbad, CA  92008.

Mr. Ferayorni's main occupation or employment is an investment 
adviser representative with Tamarack Advisers, LP, a registered 
investment adviser located at the address listed above.  

Mr. Ferayorni is the sole owner of Tamarack GP, the general 
partner of Tamarack IA, of which he also the sole limited 
partner. 

Mr. Ferayorni is the sole owner of Tamarack PFGP, the general 
partner of Tamarack GHF.

Mr. Ferayorni has not, during the past five years, been 
convicted of any criminal proceeding (excluding traffic 
violations or similar misdemeanors).

None of the reporting entities have been a party to a civil 
proceeding of a judicial or administrative body of competent 
jurisdiction and as a result of such proceeding was or is 
subject to a judgment, decree or final order enjoining future 
violations of, or prohibiting or mandating activities subject 
to, federal or state securities laws or finding any violation 
with respect to such laws.



CUSIP No. 86323X106	SCHEDULE 13D	Page 8 of 10


Item 3.   Source and Amount of Funds or Other Consideration

Funds for the purchases of Common Stock were obtained from the 
working capital of Tamarack GHF.  

Item 4.   Purpose of Transaction.

The purchases of Common Stock were made solely for investment 
purposes.  Depending upon market conditions and other factors, 
the reporting entities may increase beneficial ownership of 
securities of the Issuer, or alternatively, may dispose of some 
or all of the securities of the Issuer that it beneficially 
owns.  

Item 5.   Interest in Securities of the Issuer

(a),(b)   Reference is made hereby to Items 7-11 and 13 of pages 
          2 through 6 of this Schedule, which Items are 
          incorporated by reference herein.  

          The calculation of percentage of beneficial ownership 
          in item 13 of pages 2 through 8 were derived from the 
          Issuer's Form 10-Q filed with the Securities and 
          Exchange Commission on December 10, 2020, in which 
          The Issuer stated that the number of shares of Common
          Stock outstanding as of December 8, 2020 was 
          31,663,210 and from the Issuer's Form 8-K filed with 
          the Securities and Exchange Commission on March 4, 
          2021, in which The Issuer stated that the number of 
          shares of Common Stock outstanding was increased by 
          10,062,500 shares for a total of 41,725,710 shares.

(c)       The reporting entities acquired beneficial ownership 
          over the following stock in the last sixty days, as 
          part of their regular investment activities using
          FINRA registered broker-dealers.  

          Date               #of shares           Price
          ----------------   ----------------     $-------------
          03/02/2021           625,000            1.60


The above listed trades were effected by Tamarack GHF for which 
Tamarack PFGP serves as general partner and Tamarack IA serves 
as investment adviser in a private transaction using Craig-
Hallum Capital Group LLC as placement agent.



CUSIP No. 86323X106	SCHEDULE 13D	Page 9 of 10


(d)       No Other than the reporting persons, the additional 
          private fund, for which Tamarack PFGP serves as 
          general partner and Tamarack IA serves as investment 
          adviser, and the owners of the family accounts managed 
          by Mr. Ferayorni have the right to receive or the 
          power to direct the receipt of dividends from, or the 
          proceeds from, the sale of the common stock mentioned 
          in item 1.

(e)       Not applicable.  

Item 6.   Contracts, Arrangements, Understandings or
          Relationships with Respect to Securities of the Issuer

     None.

Item 7.   Material to be Filed as Exhibits

     None.


Signatures

After reasonable inquiry and to the best of my knowledge and 
belief, I certify that the information set forth in this 
statement is true, complete and correct.

DATED:  March 15, 2021

        Justin J. Ferayorni


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Himself

        Tamarack Capital GP, LLC


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing Member

        Tamarack Advisers, LP


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing member of its general partner

Continued on next page



CUSIP No. 86323X106	SCHEDULE 13D	Page 10 of 10


Signatures (continued)

        Tamarack Capital Management, LLC


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing member

        Tamarack Global Healthcare Fund, L.P.


        /s/ Justin J. Ferayorni
        ________________________
        By:     Justin J. Ferayorni
        Its:    Managing member of its general partner

You May Also Be Interested In

• Streamline Health® To Report Fourth Quarter and Fiscal Year 2023 Financial Performance
• HOOKIPA Pharma Inc. (HOOK) Receives FDA Clearance of INDA for HB-700
• Marriott Vacations Worldwide (VAC) ticks higher on new activist investor